SCHEDULE OF DEFERRED INCOME TAX ACTIVITY (Details) |
12 Months Ended |
|---|---|
|
Mar. 31, 2026
USD ($)
| |
| Balance as of March 31, 2025 | $ 9,318,414 |
| Foreign currency translation adjustment | 735,953 |
| Balance as of March 31, 2026 | 10,054,367 |
| Orocidin A/S [Member] | |
| Balance as of March 31, 2025 | 3,449,767 |
| Foreign currency translation adjustment | 225,776 |
| Balance as of March 31, 2026 | 3,675,543 |
| Bio-Convert A/S [Member] | |
| Balance as of March 31, 2025 | 5,868,647 |
| Foreign currency translation adjustment | 510,177 |
| Balance as of March 31, 2026 | $ 6,378,824 |
| X | ||||||||||
- Definition Amount, after deferred tax asset, of deferred tax liability attributable to taxable differences with jurisdictional netting. Reference 1: http://www.xbrl.org/2003/role/disclosureRef
|
| X | ||||||||||
- Definition Amount of tax expense (benefit), after reclassification adjustments of gain (loss) on foreign currency translation adjustments, foreign currency transactions designated and effective as economic hedges of a net investment in a foreign entity and intra-entity foreign currency transactions that are of a long-term-investment nature. Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef
|
| X | ||||||||||
- Details
|
| X | ||||||||||
- Details
|